The pharmacokinetics of recombinant human Epo (rHuEpo) were investigated after subcutaneous administration to horses. Four horses received a single 30 IU kg-' dose of rHuEpo. One horse received three repeated doses of 120 IU kg-' at 48 h intervals. Plasma erythropoietin (Epo) was measured by radioim
โฆ LIBER โฆ
Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers
โ Scribed by Wing K. Cheung; Jaya Natarajan; Marilyn Sanders; Els Vercammen
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 140 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.231
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
PHARMACOKINETICS AND HAEMATOLOGICAL PARA
โ
Agnes Souillard; Michel Audran; Francoise Bressolle; Philippe Jaussaud; Raynald
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 568 KB
Pharmacokinetics and pharmacodynamics of
โ
A. Verhagen; J. T. Ebels; J. H. G. Jonkman; A. A. Dogterom
๐
Article
๐
1995
๐
Springer
๐
English
โ 331 KB
The pharmacokinetics and pharmacodynamics of recombinant human growth hormone (rhGH) were studied after a single subcutaneous dose given by jet-injection, and have been compared with the results obtained after conventional needle-injection. Twelve healthy male volunteers completed an open label, ra